Comparison of percutaneous device closure versus surgical closure of peri-membranous ventricular septal defects: A systematic review and meta-analysis-Reference-Cited by-同舟云学术

Comparison of percutaneous device closure versus surgical closure of peri-membranous ventricular septal defects: A systematic review and meta-analysis

Published:2015-08-10 Issue:6 Volume:86 Page:1048-1056
ISSN:1522-1946
Container-title:Catheterization and Cardiovascular Interventions
language:en
Short-container-title:Cathet. Cardiovasc. Intervent.

Author:

Saurav Alok¹,Kaushik Manu²,Mahesh Alla Venkata¹,White Michael D.¹,Satpathy Ruby³,Lanspa Thomas¹,Mooss Aryan N.¹,DelCore Michael G.¹

Affiliation:

1. Division of Cardiology; Creighton University Medical Center; Omaha Nebraska

2. Division of Cardiology; VA Nebraska-Western Iowa Health System; Omaha Nebraska

3. Division of Cardiology; Alegent Creighton Heart and Vascular Institute; Omaha Nebraska

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine,Radiology, Nuclear Medicine and imaging,General Medicine

Reference25 articles.

1. The incidence of congenital heart disease;Hoffman;J Am Coll Cardiol,2002

2. ACC/AHA 2008 guidelines for the management of adults with congenital heart disease: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to develop guidelines on the management of adults with congenital heart disease);Warnes;Circulation,2008

3. Task Force on the Management of Grown-up Congenital Heart Disease of the European Society of Cardiology (ESC), Association for European Paediatric Cardiology (AEPC), ESC Committee for Practice Guidelines (CPG). ESC guidelines for the management of grown-up congenital heart disease (new version 2010);Baumgartner;Eur Heart J,2010

4. Amplatzer Muscular Ventricular Septal Defect Investigators. Device closure of muscular ventricular septal defects using the Amplatzer muscular ventricular septal defect occluder: Immediate and mid-term results of a U.S;Holzer;registry. J Am Coll Cardiol,2004

5. Catheter closure of perimembranous ventricular septal defects using the new Amplatzer membranous VSD occluder: Initial clinical experience;Hijazi;Catheter Cardiovasc Interv,2002

Cited by 68 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Characteristics of the Device and Conduction Disturbances in Transcatheter Device Closure of Perimembranous Ventricular Septal Defects;Circulation Journal;2024-08-23

2. Transcatheter closure of ventricular septal defects by exclusive transvenous antegrade cannulation from the right ventricle;2024-05-29

3. Pediatric Catheter Intervention;Pediatric Cardiology;2024

4. Transcatheter Ventricular Septal Defect Closure with Lifetech™ Konar-MF Occluder in Infants Under 10 kg with Only Using Venous Access;Pediatric Cardiology;2023-12-11

5. Safety and efficacy of Amplatzer duct occluder II and konar-MF™ VSD occluder in the closure of perimembranous ventricular septal defects in children weighing less than 10 kg;Frontiers in Cardiovascular Medicine;2023-11-29